Handelsbanken Fonder AB Purchases 4,400 Shares of Teleflex Incorporated $TFX

Handelsbanken Fonder AB raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 35.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,700 shares of the medical technology company’s stock after buying an additional 4,400 shares during the quarter. Handelsbanken Fonder AB’s holdings in Teleflex were worth $2,043,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Norges Bank purchased a new position in Teleflex during the 2nd quarter valued at about $65,826,000. Thrivent Financial for Lutherans lifted its holdings in shares of Teleflex by 1,161.0% during the third quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock valued at $67,353,000 after purchasing an additional 506,796 shares during the last quarter. Qube Research & Technologies Ltd boosted its position in shares of Teleflex by 100.1% in the 2nd quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock worth $71,821,000 after purchasing an additional 303,521 shares in the last quarter. Wedge Capital Management L L P NC purchased a new stake in shares of Teleflex in the 3rd quarter worth approximately $26,929,000. Finally, Boston Partners increased its position in Teleflex by 112.5% during the 2nd quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock valued at $45,085,000 after buying an additional 201,652 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX opened at $119.46 on Thursday. The company’s 50-day simple moving average is $111.25 and its two-hundred day simple moving average is $118.70. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. The stock has a market capitalization of $5.28 billion, a P/E ratio of -5.81, a P/E/G ratio of 0.78 and a beta of 0.87. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $143.32.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The company had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The business’s revenue was down 28.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.89 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex’s payout ratio is currently -6.62%.

Analyst Upgrades and Downgrades

Several research firms have commented on TFX. Needham & Company LLC boosted their target price on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Truist Financial upped their price target on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Royal Bank Of Canada raised their price objective on shares of Teleflex from $115.00 to $125.00 and gave the company a “sector perform” rating in a research note on Friday, February 27th. Zacks Research downgraded shares of Teleflex from a “hold” rating to a “strong sell” rating in a research note on Monday. Finally, Wells Fargo & Company raised their price target on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $140.83.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.